Intertek announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, through the acquisition of a new 20,000 sq. ft facility.
The current facility provides pharmaceutical analysis and formulation development services, with specialist expertise in orally inhaled and nasal drug products.
It is located adjacent to Intertek’s current Good Manufacturing Practice (GMP) laboratory and will expand the inhalation and nasal testing resources.
The facility will also provide a dedicated laboratory space focused on formulation development of inhaled biologics to meet increasing demand from clients globally.
This expansion will help to deliver a superior customer service for our clients around the world.
The new facility is currently being developed and is expected to open towards the end of 2019.
It provides capacity for over 100 additional employees to be recruited over the next four years.
|Scheduled to open by 2019 end